Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia

PHASE2TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

September 30, 2014

Conditions
AnemiaUnexplained Anemia (UAE)
Interventions
DRUG

iron sucrose

Patients will receive intravenous iron sucrose preparation at a dose of 200 mg per week through a peripheral intravenous catheter.

DRUG

iron sucrose

Following 12 weeks of observation patients will receive intravenous iron sucrose preparation at a dose of 200 mg per week through a peripheral intravenous catheter.

Trial Locations (5)

21224

Johns Hopkins University Geriatrics Center, Baltimore

22042

Institute For Advanced Studies in Aging, Falls Church

44106

Case Western Reserve University Medical Center, Cleveland

60612

University of Illinois, Chicago, Chicago

60637

University of Chicago Medical Center, Chicago

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Duke University

OTHER